Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure
Authors:
- Sabine Genth-ZotzSGSabine Genth-Zotz
- Stephan von HaehlingSHStephan von Haehling
- Aidan P BolgerABAidan P Bolger
- Paul R KalraPKPaul R Kalra
- Roland WenselRWRoland Wensel
- Andrew J.S CoatsACAndrew J.S Coats
- Stefan D AnkerSAStefan D Anker
- 1 December 2002
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 90 (11) , 1226-1230
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cytokine mRNA quantification by real-time PCRJournal of Immunological Methods, 2002
- Preoperative and Postoperative Endotoxemia in Children With Congenital Heart DiseaseChest, 2000
- Endotoxin and immune activation in chronic heart failure: a prospective cohort studyThe Lancet, 1999
- Cytokine generation capacities of monocytes are reduced in patients with severe heart failureAmerican Heart Journal, 1998
- Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathyInternational Journal of Cardiology, 1998
- Elevated soluble CD14 receptors and altered cytokines in chronic heart failureThe American Journal of Cardiology, 1997
- Wasting as independent risk factor for mortality in chronic heart failureThe Lancet, 1997
- Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure.Circulation, 1994
- A simple turbidimetric time assay of the endotoxin in plasmaJournal of Biochemical and Biophysical Methods, 1989
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988